SAN DIEGO, Sept. 14, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that subsidiary HempMeds® is sponsoring the seventh and last-ever annual Run 4 Hope Festival and 5K in Coppell, TX on Saturday, September 15, 2018.
Run 4 Hope is in memory of Harper Elle Howard, the little girl with CDKL5 epilepsy who helped bring medical marijuana to Latin America, and lost her battle to a CDKL5 disorder on Jan. 8, 2016. According to the International Foundation for CDKL5 Research, there are fewer than 1,000 diagnosed cases of this rare, life-threatening genetic disorder worldwide, with one in 22 people diagnosed with epilepsy. Additionally, Harper's brain is the first to be donated to CDKL5 research in another effort to help find a cure.
"Medical Marijuana, Inc. and its subsidiary HempMeds® are proud to be a part of the Run 4 Hope for the seventh and final time. Our company is humbled to support a cause that we hold so dear to our hearts," said Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus. "The passion found at these events reminds us why we continue to educate and research the many therapeutic uses of cannabidiol (CBD)."
"The Run 4 Hope Festival is my way of giving back to what hemp CBD products gave to Harper and continues to give to my family," said Penny Howard, mother of Harper and founder of the Hope for Harper non-profit organization. "We want to continue spreading awareness of CDKL5 and the treatments available for those patients and their families."
The final run will take place at the Andy Brown Park East, located at 260 Parkway Blvd in Coppell, TX 75019. The 5K will begin at 8 a.m. and the one-mile run will begin at 8:30 a.m. More information about the 7th Annual Run 4 Hope Festival and 5K can be found here.
HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC: MJNA) and the Company's exclusive master distributor and contracted marketing company, handling sales and distribution.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
SOURCE Medical Marijuana, Inc.